This inventor holds 1 USPTO granted patent. Top assignee: Laboratoire L. Lafon. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Serge Fermandjian
Introduction
Serge Fermandjian is a notable inventor based in Meudon, France. He has made significant contributions to the field of pharmaceuticals, particularly with his work on topoisomerase II inhibitors. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing medical science.
Latest Patents
Serge Fermandjian holds a patent for a topoisomerase II inhibitor. This invention is crucial in the development of new therapeutic strategies for various diseases, particularly cancer. The patent reflects his commitment to finding solutions that can improve patient outcomes.
Career Highlights
Fermandjian is currently associated with Laboratoire L. Lafon, where he continues to work on groundbreaking research. His career is marked by a focus on innovative drug development and a passion for enhancing therapeutic options available to patients.
Collaborations
Throughout his career, Serge has collaborated with esteemed colleagues such as Valérie Frere-Gallois and Frédéric Troalen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the pursuit of innovative solutions in the pharmaceutical industry.
Conclusion
Serge Fermandjian's contributions to the field of pharmaceuticals through his patent on topoisomerase II inhibitors highlight his role as an influential inventor. His work at Laboratoire L. Lafon and collaborations with other professionals underscore his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile